RxDoctor Payments Data

Ashley Mackintosh, PA

Physician Assistant · Charleston, SCNPI 1366739385

Payments from drug & device makers

$9,047in general payments, 2019–2025

Across 428 payments — averaging $21.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$655
  • Novartis$638
  • E.r. Squibb & Sons, L.L.C.$533
  • Johnson & Johnson$528
  • Pfizer$451
  • AstraZeneca$304
  • plus $6K from 54 others

What the payments were for

  • Food & beverage$8,99499%
  • Education$531%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merck29$655
Novartis28$638
E.r. Squibb & Sons, L.L.C.30$533
Johnson & Johnson(2 entities)24$528
Pfizer22$451
AstraZeneca(2 entities)17$304
Lilly USA, LLC13$300
Regeneron Healthcare Solutions, Inc.15$290
Amgen14$285
Genentech USA, Inc.12$268
Takeda Pharmaceuticals U.S.A., Inc.11$261
Gilead(2 entities)12$257
AbbVie13$242
Sanofi8$223
Daiichi Sankyo Inc.10$221
Bristol Myers Squibb11$213
Puma Biotechnology, Inc.10$178
Seagen Inc.8$170
Jazz Pharmaceuticals Inc.8$167
Bayer8$166
Beigene USA, Inc.7$153
Incyte Corporation6$137
Taiho Oncology, Inc.6$132
Pharmaessentia USA Corporation6$131
GSK7$128
ADC Therapeutics America, Inc.6$124
Boehringer Ingelheim4$117
Rigel Pharmaceuticals, Inc.6$109
Sobi, Inc5$95
AVEO Pharmaceuticals, Inc.4$94
Tersera Therapeutics LLC4$90
Karyopharm Therapeutics Inc.4$86
Astellas Pharma US Inc4$80
Array Biopharma Inc3$73
Exelixis Inc.4$68
Azurity Pharmaceuticals, Inc.2$64
Stemline Therapeutics Inc.2$64
Ipsen Biopharmaceuticals, Inc3$62
Alnylam Pharmaceuticals Inc.3$62
Beone Medicines USA, Inc.2$59
Servier Pharmaceuticals LLC3$56
Adaptive Biotechnologies Corporation2$48
EUSA Pharma (US) LLC2$42
Syndax Pharmaceuticals, Inc.2$41
Iovance Biotherapeutics, Inc.1$36
Tempus AI, Inc1$35
EMD Serono, Inc.2$30
Sumitomo Pharma America, Inc.1$29
CTI Biopharma Corp.2$27
Dendreon Pharmaceuticals LLC1$25
Fennec Pharmaceuticals, Inc.1$25
G1 Therapeutics, Inc.1$25
Genmab U.S., Inc.1$24
Eisai Inc.1$24
Pharmaand GmbH1$23
Tolmar, Inc.1$23
Novocure Inc.1$23
Mirati Therapeutics, Inc.1$23
Springworks Therapeutics, Inc.1$22
Recordati_rare_diseases_inc.1$21

How this compares

$9,047 in reported general payments places this provider in the 95th percentile of 1,852 physician assistant providers in South Carolina.

See all physician assistant providers in South Carolina

Medicare billing

Part B allowed, 2024
$62,209
Medicare patients
344
Services billed
682

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RevlimidLenalidomide18$309,077
VerzenioAbemaciclib20$304,655
IbrancePalbociclib18$275,794
PomalystPomalidomide11$246,457
NubeqaDarolutamide23$233,967
ErleadaApalutamide16$232,989
XtandiEnzalutamide13$185,704
BrukinsaZanubrutinib12$162,101
OrgovyxRelugolix24$63,869
EliquisApixaban48$36,457
Letrozole14$616
Hydroxyurea21$558
Anastrozole39$503
Potassium Chloride30$431
Dexamethasone13$269

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerIbrance, Eliquis$451$312,25166 claims
Bristol Myers SquibbRevlimid$213$309,07718 claims
Lilly USA, LLCVerzenio$300$304,65520 claims
E.r. Squibb & Sons, L.L.C.Pomalyst$533$246,45711 claims
BayerNubeqa$166$233,96723 claims
Johnson & JohnsonErleada$528$232,98916 claims
Astellas Pharma US IncXtandi$80$185,70413 claims
Beigene USA, Inc.Brukinsa$153$162,10112 claims
Sumitomo Pharma America, Inc.Orgovyx$29$63,86924 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,852 physician assistant providers in South Carolina.

Other physician assistant in Charleston

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →